Tesofensine
Triple monoamine reuptake inhibitor with strong weight-loss data; not FDA-approved.
Scientific Overview
Phase III trial (2010) showed ~10% weight loss at 0.5 mg/day. Original Alzheimer's program scrapped; revived for obesity in some regions (Mexico, Argentina).
Key Research Benefits
- ✓Significant weight loss
- ✓Appetite suppression
- ✓Energy boost
Potential Side Effects
Research Protocols
Common DosagesDaily Oral
“Cycle 4–12 weeks; monitor cardiovascular”
Dose Calculator
🧮 Peptide Reconstitution Calculator
Total amount of peptide in the vial.
Volume of water used to mix.
Draw to this mark
or 0.10 mL on a U-100 syringe
Explore Tesofensine
Where to source
Vendors with public COAs that stock this category. Affiliate links are disclosed.
- Limitless Life NootropicsFL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.COA: JanoshikAffiliate disclosed
- SwissChems60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.COA: JanoshikAffiliate disclosed
- Amino ClubEU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.COA: Third-partyAffiliate disclosed
Tesofensine by goal
Read Tesofensine's profile filtered through specific research goals.
Molecular Profile
Quick Reference
- Status
- Research Compound
- Category
- Metabolic
- Common Dosage
- 0.25–0.5 mg
- Daily AM
Strictly for research purposes. Not for human consumption.
Related tools
Medical Disclaimer
Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.